An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35278204/
Biological therapies have revolutionized the treatment of disease across a number of therapeutic areas including retinal diseases. However, on occasion, such treatments may be relatively more expensive compared to small molecule therapies. This can restrict patient access and treatment length leadin ...
Conclusion: The current review provides an introduction to biosimilars with the aim of preparing retinal specialists for discussing these products with their patients.